Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.91 USD | -5.21% | +10.65% | +103.50% |
16/07 | ChromaDex Corp. Announces Pharmaceutical-Grade Intravenous and Injectable Niagen®? Will Debut At Leading Wellness Clinics in August | CI |
01/07 | ChromaDex Joins Russell 2000 Index | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+103.50% | 232M | |
+24.74% | 47.96B | |
-0.47% | 42.45B | |
+43.96% | 41.47B | |
+25.40% | 31.6B | |
+17.96% | 28.63B | |
-4.47% | 28.03B | |
+50.73% | 14.56B | |
+42.56% | 14.14B | |
+1.46% | 12.58B |
- Stock Market
- Equities
- CDXC Stock
- News ChromaDex Corporation
- ChromaDex Corp. Appoints Mark Friedman as General Counsel and Corporate Secretary